Bioxytran, Inc. is a U.S.-based clinical-stage biotechnology company focused on developing innovative therapies for hypoxia-related conditions, viral infections, and degenerative diseases. The company leverages advanced carbohydrate-based drug design and galectin inhibitor technology to create treatments aimed at stroke, wound healing, and infectious diseases like COVID-19. Its pipeline includes promising drug candidates such as oxygen-carrying therapeutics, antiviral agents and anti-metastasis for cancer designed to address critical unmet medical needs and improve patient outcomes.
-
1 Articles
-
1 Photos
-
0 Vidéos
-
Habitant Needham
-
Du Needham
-
Suivi par 0 membre
Rechercher
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
